Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 3
2018 4
2019 1
2020 1
2021 2
2023 9
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean nankai ju[Author] (123 results)?
Hematopoietic Stem Cell Heterogeneity Is Linked to the Initiation and Therapeutic Response of Myeloproliferative Neoplasms.
Tong J, Sun T, Ma S, Zhao Y, Ju M, Gao Y, Zhu P, Tan P, Fu R, Zhang A, Wang D, Wang D, Xiao Z, Zhou J, Yang R, Loughran SJ, Li J, Green AR, Bresnick EH, Wang D, Cheng T, Zhang L, Shi L. Tong J, et al. Among authors: ju m. Cell Stem Cell. 2021 Mar 4;28(3):502-513.e6. doi: 10.1016/j.stem.2021.01.018. Epub 2021 Feb 22. Cell Stem Cell. 2021. PMID: 33621485 Free article.
Efficacy and safety of eltrombopag in the treatment of immune thrombocytopenia patients with hepatitis B virus infection: A prospective, multicenter, single arm, phase II trial.
Chen Y, Xu Y, Huang Y, Sun T, Hu Y, Xue F, Peng X, Lai Y, Zhou Z, Zhou H, Zhou R, Liu W, Liu X, Dong H, Fu R, Ju M, Dai X, Li H, Liu X, Ma Y, Song Z, Peng J, Yang R, Zhang L. Chen Y, et al. Among authors: ju m. Am J Hematol. 2024 Jan;99(1):E22-E25. doi: 10.1002/ajh.27141. Epub 2023 Oct 26. Am J Hematol. 2024. PMID: 37883528 Clinical Trial. No abstract available.
Single-dose rituximab plus glucocorticoid versus cyclophosphamide plus glucocorticoid in patients with newly diagnosed acquired hemophilia A: A multicenter, open-label, randomized noninferiority trial.
Wang P, Zhou R, Xue F, Zhou H, Bai J, Wang X, Ma Y, Song Z, Chen Y, Liu X, Fu R, Sun T, Ju M, Dai X, Dong H, Yang R, Liu W, Zhang L. Wang P, et al. Among authors: ju m. Am J Hematol. 2024 Jan;99(1):28-37. doi: 10.1002/ajh.27128. Epub 2023 Oct 18. Am J Hematol. 2024. PMID: 37851608 Clinical Trial.
Multilevel defects in the hematopoietic niche in essential thrombocythemia.
Sun T, Ju M, Dai X, Dong H, Gu W, Gao Y, Fu R, Liu X, Huang Y, Liu W, Ch Y, Wang W, Li H, Zhou Y, Shi L, Yang R, Zhang L. Sun T, et al. Among authors: ju m. Haematologica. 2020 Mar;105(3):661-673. doi: 10.3324/haematol.2018.213686. Epub 2019 Jul 9. Haematologica. 2020. PMID: 31289202 Free PMC article.
ASXL1 mutations in Chinese patients with essential thrombocythemia.
Nie YB, Sun M, He CK, Ju MK, Zhou FL, Wu SY, Zhou Y, Liu L, Shen H, Huang TT, Liu P, Xu Y, Shao L, Zuo XL. Nie YB, et al. Exp Ther Med. 2018 May;15(5):4149-4156. doi: 10.3892/etm.2018.5939. Epub 2018 Mar 9. Exp Ther Med. 2018. PMID: 29725364 Free PMC article.
24 results